Skip Navigation



Human Molecular Genetics Advance Access published online on December 20, 2007
Human Molecular Genetics, doi:10.1093/hmg/ddm356
This Article
Right arrow Advance Access manuscript (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
17/6/844    most recent
ddm356v2
ddm356v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hwang, C.-H.
Right arrow Articles by Wu, D. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hwang, C.-H.
Right arrow Articles by Wu, D. K
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press 2007

Noggin heterozygous mice: an animal model for congenital conductive hearing loss in humans

Chan-Ho Hwang and Doris K Wu*

Lab of Molecular Biology, National Institute on Deafness and Other Communication Disorders, Rockville, Maryland, 20850, USA

Correspondence should be addressed to: Doris K.Wu, Ph.D. Lab of Molecular Biology, NIDCD/NIH, 5 Research Court, Rm 2B34, Rockville, MD 20850, Tel: (301) 402-4214, Fax: (301) 402-5475 email: wud{at}nidcd.nih.gov

Received September 13, 2007; Revised November 30, 2007; Accepted November 30, 2007

Conductive hearing loss occurs when sound waves are not relayed efficiently to the inner ear. Mutations of the NOGGIN (NOG) gene in humans are associated with several autosomal dominant disorders such as proximal symphalangism and multiple synostoses. These syndromes are characterized by skeletal defects and synostoses, which include conductive hearing loss. Noggin is an antagonist of bone morphogenetic proteins (Bmps), and balanced levels of Bmps and Noggin are required for proper skeletal formation. Depending on the genetic background, some of the Nog+/- mice display mild hearing loss that is conductive in nature. Since Noggin is a single exon gene, this data strongly suggest that the autosomal dominant disorders associated with NOG mutations are due to haploinsufficiency of NOGGIN. The conductive hearing loss in Nog+/- mice is caused by an ectopic bone bridge located between the stapes and the posterior wall of the tympanum, which affects the normal mobility of the ossicle. Our analyses suggest that the ectopic bone formation is caused by a failure of the stapes and styloid process to separate completely during development. This failure of bone separation in the Nog+/- mice reveals another consequence of chondrocyte hyperplasia due to unopposed Bmp activities in these mutants such as Bmp4 and Bmp14 (Gdf5). More importantly, these results establish Nog+/- mice as the first animal model for the study of conductive rather than neurosensory hearing loss that has direct relevance to human genetic disorders.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.